Home
Conditions
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

294 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

NCT01129193

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +118 more
Locations: The Ohio State University James Cancer Hospital Columbus, Ohio, United States

View Trial Details

Completed

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

NCT01567709

Conditions: Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, +84 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations: Institut Jules Bordet Brussels, Belgium

CHU de Grenoble - Hopital de la Tronche Grenoble, France

German Hodgkin's Lymphoma Study Group Cologne, Germany

Ospedale San Martino Genoa, Italy

View Trial Details

Completed

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

NCT00005985

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: University of Minnesota Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma

NCT00406757

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Tokyo, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant

NCT00238368

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

NCT00301951

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +55 more
Locations: UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

NCT01254578

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +96 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

NCT00072514

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions